Cite

HARVARD Citation

    Handley, A. et al. (2016). Safety and tolerability of azilsartan medoxomil in subjects with essential hypertension: a one-year, phase 3, open-label study. Clinical and experimental hypertension. pp. 180-188. [Online]. 
  
Back to record